Continuous Blood Glucose Monitoring Market to 2027 - Global Analysis and Forecasts by Component (Insulin Pumps, Sensors, and Transmitters and Receivers); Testing Site (Alternate Site Testing, Finger Tip, and Others); and Application (Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, and Critical Care Patients)
Report Code: TIPHE100000865 No. of Pages: 150 Category: Medical Device Status: Upcoming
Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.
The mounting inclination of patients towards real-time health monitoring and availability of reliable, frequent, and real time track assistance are the major drivers which are likely to propel the growth of continuous blood glucose monitoring system market. Increase in the prevalence of diabetic patients, rising attention towards health awareness, and increasing affordability of devices are likely to add new opportunities for this market in the coming years.
The "Global Continuous Blood Glucose Monitoring System Market Analysis to 2027" is a specialized and in-depth study of the continuous blood glucose monitoring system industry with a focus on the global market trend. The report aims to provide an overview of global continuous blood glucose monitoring system market with detailed market segmentation by components, testing sites, application, and geography. The global continuous blood glucose monitoring system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The continuous blood glucose monitoring system market is segmented based on components which is further sub- segmented into the insulin pumps, sensors, and transmitters and receivers. The testing site segment is sub divided into alternate site testing, fingertip, and others. Some of the key applications of continuous blood glucose monitoring system are Type 1 diabetic patients, Type 2 diabetic patients, gestational diabetes, and critical care patients, among others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global continuous blood glucose monitoring system market based on components, testing site, and application. It also provides market size and forecast till 2027 for overall continuous blood glucose monitoring system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key continuous blood glucose monitoring system manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Dexcom, Inc., Abbott, Bayer AG, F. Hoffmann-La Roche, Arkray Inc., Cellnovo, Echo Therapeutics Inc., Nemaura, Tandem Diabetes Care, Inc., and PharmaTech Solutions, Inc. among Others.
The mounting inclination of patients towards real-time health monitoring and availability of reliable, frequent, and real time track assistance are the major drivers which are likely to propel the growth of continuous blood glucose monitoring system market. Increase in the prevalence of diabetic patients, rising attention towards health awareness, and increasing affordability of devices are likely to add new opportunities for this market in the coming years.
The "Global Continuous Blood Glucose Monitoring System Market Analysis to 2027" is a specialized and in-depth study of the continuous blood glucose monitoring system industry with a focus on the global market trend. The report aims to provide an overview of global continuous blood glucose monitoring system market with detailed market segmentation by components, testing sites, application, and geography. The global continuous blood glucose monitoring system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The continuous blood glucose monitoring system market is segmented based on components which is further sub- segmented into the insulin pumps, sensors, and transmitters and receivers. The testing site segment is sub divided into alternate site testing, fingertip, and others. Some of the key applications of continuous blood glucose monitoring system are Type 1 diabetic patients, Type 2 diabetic patients, gestational diabetes, and critical care patients, among others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global continuous blood glucose monitoring system market based on components, testing site, and application. It also provides market size and forecast till 2027 for overall continuous blood glucose monitoring system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key continuous blood glucose monitoring system manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Dexcom, Inc., Abbott, Bayer AG, F. Hoffmann-La Roche, Arkray Inc., Cellnovo, Echo Therapeutics Inc., Nemaura, Tandem Diabetes Care, Inc., and PharmaTech Solutions, Inc. among Others.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Continuous Blood Glucose Monitoring Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Continuous Blood Glucose Monitoring Market - By Component
3.2.2 Continuous Blood Glucose Monitoring Market - By Testing site
3.2.3 Continuous Blood Glucose Monitoring Market - By Application
3.2.4 Continuous Blood Glucose Monitoring Market - By Region
3.2.4.1 By Countries
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis
4 Continuous Blood Glucose Monitoring Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Continuous Blood Glucose Monitoring Market Analysis- Global
5.1 Global Continuous Blood Glucose Monitoring Market Overview
5.2 Global Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Global Continuous Blood Glucose Monitoring Market Volume Forecasts and Analysis ('000 units)
5.4 Market Positioning/Market Share
5.5 Performance of Key Players
5.6 Expert Opinions
6 Continuous Blood Glucose Monitoring Market -Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South and Central America
7 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Components (US$ Mn)
7.1 Overview
7.2 Components Market Forecasts and Analysis
7.3 Insulin Pumps Market
7.3.1 Overview
7.3.2 Insulin Pumps Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3 Insulin Pumps Market Volume Forecasts and Analysis ('000 units)
7.4 Sensors Market
7.4.1 Overview
7.4.2 Sensors Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3 Sensors Market Volume Forecasts and Analysis ('000 units)
7.5 Transmitters and Receivers Market
7.5.1 Overview
7.5.2 Sensors Market Revenue Forecasts and Analysis (US$ Mn)
7.5.3 Sensors Market Volume Forecasts and Analysis ('000 units)
8 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Testing Sites (US$ Mn)
8.1 Overview
8.2 Testing Sites Market Forecasts and Analysis
8.3 Alternate Site Testing Market
8.3.1 Overview
8.3.2 Alternate Site Testing Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Finger Tip Market
8.4.1 Overview
8.4.2 Finger Tip Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Others Market
8.5.1 Overview
8.5.2 Others Market Revenue Forecasts and Analysis (US$ Mn)
9 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Applications (US$ Mn)
9.1 Overview
9.2 Application Market Forecasts and Analysis
9.3 Type 1 Diabetic Patients Market
9.3.1 Overview
9.3.2 Type 1 Diabetic Patients Market Revenue Forecasts and Analysis (US$ Mn)
9.4 Type 2 Diabetic Patients Market
9.4.1 Overview
9.4.2 Type 2 Diabetic Patients Market Revenue Forecasts and Analysis (US$ Mn)
9.5 Gestational Diabetes Market
9.5.1 Overview
9.5.2 Gestational Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
9.6 Critical Care Patients Market
9.6.1 Overview
9.6.2 Critical Care Patients Market Revenue Forecasts and Analysis (US$ Mn)
10 North America Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
10.1 North America Continuous Blood Glucose Monitoring Market Overview
10.2 North America Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Market Forecasts and Analysis - By Component
10.4 North America Market Forecasts and Analysis - By Testing Site
10.5 North America Market Forecasts and Analysis - By Application
10.6 North America Market Forecasts and Analysis - By Country
10.7 US Market Overview
10.7.1 US Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
10.7.2 US Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
10.7.3 US Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 Canada Market Overview
10.8.1 Canada Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
10.8.2 Canada Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
10.8.3 Canada Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9 Mexico Market Overview
10.9.1 Mexico Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
10.9.2 Mexico Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
10.9.3 Mexico Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11 Europe Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
11.1 Europe Continuous Blood Glucose Monitoring Market Overview
11.2 Europe Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Continuous Blood Glucose Monitoring Market Volume Forecasts and Analysis ('000 units)
11.4 Europe Market Forecasts and Analysis - By Component
11.5 Europe Market Forecasts and Analysis - By Testing Site
11.6 Europe Market Forecasts and Analysis - By Application
11.7 Europe Market Forecasts and Analysis - By Country
11.8 UK Market Overview
11.8.1 UK Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
11.8.2 UK Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
11.8.3 UK Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9 Germany Market Overview
11.9.1 Germany Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
11.9.2 Germany Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
11.9.3 Germany Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.10 France Market Overview
11.10.1 France Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
11.10.2 France Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
11.10.3 France Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12 Asia Pacific Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
12.1 Asia Pacific Continuous Blood Glucose Monitoring Market Overview
12.2 Asia Pacific Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Market Forecasts and Analysis - By Component
12.4 Asia Pacific Market Forecasts and Analysis - By Testing Site
12.5 Asia Pacific Market Forecasts and Analysis - By Application
12.6 Asia Pacific Market Forecasts and Analysis - By Country
12.7 Japan Market Overview
12.7.1 Japan Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
12.7.2 Japan Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
12.7.3 Japan Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8 China Market Overview
12.8.1 China Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
12.8.2 China Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
12.8.3 China Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9 India Market Overview
12.9.1 India Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
12.9.2 India Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
12.9.3 India Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13 Middle East and Africa (MEA) Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
13.1 Middle East & Africa (MEA) Continuous Blood Glucose Monitoring Market Overview
13.2 Middle East & Africa (MEA) Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa (MEA) Market Forecasts and Analysis - By Component
13.4 Middle East & Africa (MEA) Market Forecasts and Analysis - By Testing Site
13.5 Middle East & Africa (MEA)Market Forecasts and Analysis - By Application
13.6 Middle East & Africa (MEA) Market Forecasts and Analysis - By Country
13.7 South Africa Market Overview
13.7.1 South Africa Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
13.7.2 South Africa Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
13.7.3 South Africa Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.8 Saudi Arabia Market Overview
13.8.1 Saudi Arabia Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
13.8.2 Saudi Arabia Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
13.8.3 Saudi Arabia Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9 UAE Market Overview
13.9.1 UAE Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
13.9.2 UAE Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
13.9.3 UAE Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14 South and Central America Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
14.1 South and Central America Continuous Blood Glucose Monitoring Market Overview
14.2 South and Central America Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Market Forecasts and Analysis - By Component
14.4 South and Central America Market Forecasts and Analysis - By Testing Site
14.5 South and Central America Market Forecasts and Analysis - By Application
14.6 South and Central America Market Forecasts and Analysis - By Country
14.7 Brazil Market Overview
14.7.1 Brazil Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
14.7.2 Brazil Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
14.7.3 Brazil Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Product Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
15.2.3 Geographic Expansions
16 Continuous Blood Glucose Monitoring Market, Key Company Profiles
16.1 Dexcom, Inc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Abbott
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Bayer AG
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 F. Hoffmann-La Roche
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 Arkray Inc.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Cellnovo
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Echo Therapeutics, Inc.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 Nemaura
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 Tandem Diabetes Care, Inc.
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 PharmaTech Solutions, Inc.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Financial Overview
16.10.4 Product Portfolio
16.10.5 Product Pipeline
16.10.6 SWOT Analysis
16.10.7 Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Continuous Blood Glucose Monitoring Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Continuous Blood Glucose Monitoring Market - By Component
3.2.2 Continuous Blood Glucose Monitoring Market - By Testing site
3.2.3 Continuous Blood Glucose Monitoring Market - By Application
3.2.4 Continuous Blood Glucose Monitoring Market - By Region
3.2.4.1 By Countries
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis
4 Continuous Blood Glucose Monitoring Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Continuous Blood Glucose Monitoring Market Analysis- Global
5.1 Global Continuous Blood Glucose Monitoring Market Overview
5.2 Global Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Global Continuous Blood Glucose Monitoring Market Volume Forecasts and Analysis ('000 units)
5.4 Market Positioning/Market Share
5.5 Performance of Key Players
5.6 Expert Opinions
6 Continuous Blood Glucose Monitoring Market -Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South and Central America
7 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Components (US$ Mn)
7.1 Overview
7.2 Components Market Forecasts and Analysis
7.3 Insulin Pumps Market
7.3.1 Overview
7.3.2 Insulin Pumps Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3 Insulin Pumps Market Volume Forecasts and Analysis ('000 units)
7.4 Sensors Market
7.4.1 Overview
7.4.2 Sensors Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3 Sensors Market Volume Forecasts and Analysis ('000 units)
7.5 Transmitters and Receivers Market
7.5.1 Overview
7.5.2 Sensors Market Revenue Forecasts and Analysis (US$ Mn)
7.5.3 Sensors Market Volume Forecasts and Analysis ('000 units)
8 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Testing Sites (US$ Mn)
8.1 Overview
8.2 Testing Sites Market Forecasts and Analysis
8.3 Alternate Site Testing Market
8.3.1 Overview
8.3.2 Alternate Site Testing Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Finger Tip Market
8.4.1 Overview
8.4.2 Finger Tip Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Others Market
8.5.1 Overview
8.5.2 Others Market Revenue Forecasts and Analysis (US$ Mn)
9 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Applications (US$ Mn)
9.1 Overview
9.2 Application Market Forecasts and Analysis
9.3 Type 1 Diabetic Patients Market
9.3.1 Overview
9.3.2 Type 1 Diabetic Patients Market Revenue Forecasts and Analysis (US$ Mn)
9.4 Type 2 Diabetic Patients Market
9.4.1 Overview
9.4.2 Type 2 Diabetic Patients Market Revenue Forecasts and Analysis (US$ Mn)
9.5 Gestational Diabetes Market
9.5.1 Overview
9.5.2 Gestational Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
9.6 Critical Care Patients Market
9.6.1 Overview
9.6.2 Critical Care Patients Market Revenue Forecasts and Analysis (US$ Mn)
10 North America Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
10.1 North America Continuous Blood Glucose Monitoring Market Overview
10.2 North America Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Market Forecasts and Analysis - By Component
10.4 North America Market Forecasts and Analysis - By Testing Site
10.5 North America Market Forecasts and Analysis - By Application
10.6 North America Market Forecasts and Analysis - By Country
10.7 US Market Overview
10.7.1 US Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
10.7.2 US Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
10.7.3 US Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 Canada Market Overview
10.8.1 Canada Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
10.8.2 Canada Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
10.8.3 Canada Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9 Mexico Market Overview
10.9.1 Mexico Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
10.9.2 Mexico Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
10.9.3 Mexico Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11 Europe Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
11.1 Europe Continuous Blood Glucose Monitoring Market Overview
11.2 Europe Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Continuous Blood Glucose Monitoring Market Volume Forecasts and Analysis ('000 units)
11.4 Europe Market Forecasts and Analysis - By Component
11.5 Europe Market Forecasts and Analysis - By Testing Site
11.6 Europe Market Forecasts and Analysis - By Application
11.7 Europe Market Forecasts and Analysis - By Country
11.8 UK Market Overview
11.8.1 UK Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
11.8.2 UK Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
11.8.3 UK Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9 Germany Market Overview
11.9.1 Germany Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
11.9.2 Germany Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
11.9.3 Germany Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.10 France Market Overview
11.10.1 France Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
11.10.2 France Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
11.10.3 France Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12 Asia Pacific Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
12.1 Asia Pacific Continuous Blood Glucose Monitoring Market Overview
12.2 Asia Pacific Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Market Forecasts and Analysis - By Component
12.4 Asia Pacific Market Forecasts and Analysis - By Testing Site
12.5 Asia Pacific Market Forecasts and Analysis - By Application
12.6 Asia Pacific Market Forecasts and Analysis - By Country
12.7 Japan Market Overview
12.7.1 Japan Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
12.7.2 Japan Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
12.7.3 Japan Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8 China Market Overview
12.8.1 China Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
12.8.2 China Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
12.8.3 China Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9 India Market Overview
12.9.1 India Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
12.9.2 India Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
12.9.3 India Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13 Middle East and Africa (MEA) Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
13.1 Middle East & Africa (MEA) Continuous Blood Glucose Monitoring Market Overview
13.2 Middle East & Africa (MEA) Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa (MEA) Market Forecasts and Analysis - By Component
13.4 Middle East & Africa (MEA) Market Forecasts and Analysis - By Testing Site
13.5 Middle East & Africa (MEA)Market Forecasts and Analysis - By Application
13.6 Middle East & Africa (MEA) Market Forecasts and Analysis - By Country
13.7 South Africa Market Overview
13.7.1 South Africa Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
13.7.2 South Africa Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
13.7.3 South Africa Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.8 Saudi Arabia Market Overview
13.8.1 Saudi Arabia Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
13.8.2 Saudi Arabia Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
13.8.3 Saudi Arabia Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9 UAE Market Overview
13.9.1 UAE Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
13.9.2 UAE Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
13.9.3 UAE Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14 South and Central America Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2027 - Country Analysis
14.1 South and Central America Continuous Blood Glucose Monitoring Market Overview
14.2 South and Central America Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Market Forecasts and Analysis - By Component
14.4 South and Central America Market Forecasts and Analysis - By Testing Site
14.5 South and Central America Market Forecasts and Analysis - By Application
14.6 South and Central America Market Forecasts and Analysis - By Country
14.7 Brazil Market Overview
14.7.1 Brazil Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis -By Component (US$ Mn)
14.7.2 Brazil Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Testing Site (US$ Mn)
14.7.3 Brazil Continuous Blood Glucose Monitoring Market Revenue Forecasts and Analysis-By Application (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Product Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
15.2.3 Geographic Expansions
16 Continuous Blood Glucose Monitoring Market, Key Company Profiles
16.1 Dexcom, Inc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Abbott
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Bayer AG
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 F. Hoffmann-La Roche
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 Arkray Inc.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Cellnovo
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Echo Therapeutics, Inc.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 Nemaura
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 Tandem Diabetes Care, Inc.
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 PharmaTech Solutions, Inc.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Financial Overview
16.10.4 Product Portfolio
16.10.5 Product Pipeline
16.10.6 SWOT Analysis
16.10.7 Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
The List of Companies
1. Dexcom, Inc.
2. Abbott
3. Bayer AG
4. F. Hoffmann-La Roche
5. Arkray Inc.
6. Cellnovo
7. Echo Therapeutics Inc.
8. Nemaura
9. Tandem Diabetes Care, Inc.
10. PharmaTech Solutions, Inc.
1. Dexcom, Inc.
2. Abbott
3. Bayer AG
4. F. Hoffmann-La Roche
5. Arkray Inc.
6. Cellnovo
7. Echo Therapeutics Inc.
8. Nemaura
9. Tandem Diabetes Care, Inc.
10. PharmaTech Solutions, Inc.